You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Poliovirus receptor-related immunoglobulin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Neovascular Age-Related Macular Degeneration Trial in Shanghai (HB002.1M)

Completed
  • Neovascular Age-Related Macular Degeneration
  • Shanghai, Shanghai, China
    Shanghai General Hospital
Jul 28, 2020

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),

Not yet recruiting
  • Poliomyelitis
  • Novel oral poliomyelitis vaccine type 1 (nOPV1)
  • +3 more
  • Dhaka, Bangladesh
    International Centre for Diarrhoeal Disease Research
Nov 14, 2023

Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab

Completed
  • Multiple Sclerosis
    • East Hanover, New Jersey
      Novartis
    Jul 14, 2023

    Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy, Inflammatory Polyneuropathy Trial in Arlington Heights (Panzyga IVIG,

    Not yet recruiting
    • Small Fiber Neuropathy
    • +3 more
    • Panzyga IVIG
    • Placebo
    • Arlington Heights, Illinois
      Northwest Community Healthcare
    Aug 22, 2022

    Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)

    Not yet recruiting
    • Advanced/Metastatic Solid Tumors
    • Kurralta Park, South Australia, Australia
    • +1 more
    Nov 9, 2022

    Immunoglobulin E-Mediated Food Allergy, Immunoglobulin G4-Related Disease, Symptoms and Signs Trial in Madrid (Food-specific

    Recruiting
    • Immunoglobulin E-Mediated Food Allergy
    • +3 more
    • Food-specific Immunoglobulin G4 and/or Immunoglobulin E antibody reactions
    • Madrid, Spain
      Universidad Politécnica de Madrid
    Jan 3, 2023

    Immunoglobulin A Nephropathy Trial (SM101, Placebo)

    Withdrawn
    • Immunoglobulin A Nephropathy
    • SM101
    • Placebo
    • (no location specified)
    Feb 3, 2022

    IgA Nephropathy (IgAN), Berger Disease, Glomerulonephritis, IgA Trial in Worldwide (Placebo, Cemdisiran)

    Active, not recruiting
    • IgA Nephropathy (IgAN)
    • +2 more
    • Vancouver, British Columbia, Canada
    • +19 more
    Jan 13, 2023

    Immunoglobulin A Nephropathy, Kidney Diseases, Glomerulonephritis, IGA Trial in Leicester (Sparsentan)

    Recruiting
    • Immunoglobulin A Nephropathy
    • +5 more
    • Leicester, United Kingdom
      Leicester General Hospital, University Hospitals of Leicester NH
    May 18, 2022

    Severe Combined Immunodeficiency, X-Linked Trial in London (Lentiviral vector transduced CD34+ cells)

    Recruiting
    • Severe Combined Immunodeficiency, X-Linked
    • Lentiviral vector transduced CD34+ cells
    • London, Greater London, United Kingdom
      Great Ormond Street Hospital for Children NHS Foundation Trust
    Mar 15, 2022

    Poliomyelitis Trial in Dhaka (SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A, SII Inactivated Salk Polio Vaccine

    Recruiting
    • Poliomyelitis
    • SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A
    • +3 more
    • Dhaka, Bangladesh
      International Centre for Diarrhoeal Disease Research, Bangladesh
    Dec 24, 2022

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +3 more
    • Biospecimen Collection
    • +7 more
    • Portland, Oregon
      SWOG
    Sep 27, 2023

    Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Richter's Transformation
    • Boston, Massachusetts
    • +1 more
    Sep 12, 2023

    Functional FcERI/RII on the Surface of Human Blood Platelet

    Not yet recruiting
    • Allergy
    • Flow cytometry
    • Strasbourg, France
      Les Hôpitaux Universitaires
    May 4, 2023

    MRD Detection by NGS in Pediatric B-ALL

    Completed
    • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
    • MRD
    • Hangzhou, Zhejiang, China
      The Children's Hospital of Zhejiang University School of Medicin
    Jul 25, 2023

    Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

    Not yet recruiting
    • Blood Disease
    • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
    • CliniMACS® System
    • (no location specified)
    Jan 30, 2023

    Poliomyelitis Trial in Wilrijk, Ghent (Novel OPV2 candidate 1, Novel OPV2 candidate 2, Placebo)

    Completed
    Has Results
    • Poliomyelitis
    • Novel OPV2 candidate 1
    • +2 more
    • Wilrijk, Antwerp, Belgium
    • +1 more
    Sep 18, 2021

    Poliomyelitis Trial (nOPV2)

    Not yet recruiting
    • Poliomyelitis
    • nOPV2
    • (no location specified)
    Dec 22, 2022

    Acute Myeloid Leukemia Trial in Valencia (AFM28)

    Recruiting
    • Acute Myeloid Leukemia
    • Valencia, Spain
      Hospital Universitari i Politècnic La Fe
    Apr 5, 2023

    Multiple Myeloma Trial in Beijing, Guangzhou, Shanghai (TQB2934 injection)

    Not yet recruiting
    • Multiple Myeloma
    • TQB2934 injection
    • Beijing, Beijing, China
    • +2 more
    Dec 8, 2022

    IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

    Recruiting
    • IgG4-related Disease With Eosinophilia
    • Beijing, Bejing, China
      Peking Union Medical College Hospital
    Mar 23, 2023